{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:30:31Z","timestamp":1774618231396,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To determine the incremental cost of directly observed therapy (DOT) for patients with tuberculosis at low risk for treatment default, we applied a model of DOT effectiveness to 1,377 low-risk patients in California during 1995. The default rate for this cohort, which consisted of those with no recent history of substance abuse, homelessness, or incarceration, was 1.7%. The model predicted that DOT and self-administered therapy (SAT) cured 93.1 and 90.8% of these patients, respectively. DOT would initially cost $1.83 million more than SAT, but avert $569,191 in treatment cost for relapse cases and their contacts, for a net incremental cost of $1.27 million ($919 per patient treated), or $40,620 per additional case cured. The cost-effectiveness of DOT was sensitive to the default rate and relapse rate after completing SAT. DOT would generate cost savings only when the default and relapse rates were more than 32.2 and 9.2%, respectively. Given the low default rate and resulting high incremental cost of DOT, provision of DOT to low-risk patients in California should be evaluated in the context of resource availability, competing program priorities, and program success in completing self-administered therapy with a low relapse rate.<\/jats:p>","DOI":"10.1164\/ajrccm.160.2.9901049","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:03:51Z","timestamp":1365084231000},"page":"582-586","source":"Crossref","is-referenced-by-count":20,"title":["Cost-effectiveness Analysis of Directly Observed Therapy for Patients with Tuberculosis at Low Risk for Treatment Default"],"prefix":"10.1093","volume":"160","author":[{"given":"DAVID C.","family":"SNYDER","sequence":"first","affiliation":[{"name":"California Department of Health Services, Tuberculosis Control Branch, Berkeley; and Francis J. Curry National Tuberculosis Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANIEL P.","family":"CHIN","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Tuberculosis Control Branch, Berkeley; and Francis J. Curry National Tuberculosis Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,8,1]]},"reference":[{"key":"2026032708464964100_B1"},{"key":"2026032708464964100_B2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.279.12.943","article-title":"Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the public health tuberculosis guidelines panel.","volume":"279","author":"Chaulk","year":"1998","journal-title":"J.A.M.A."},{"key":"2026032708464964100_B3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1056\/NEJM199302253280811","article-title":"Directly observed treatment for tuberculosis: we can't afford not to try it.","volume":"328","author":"Iseman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"2026032708464964100_B4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0272-5231(05)70365-8","article-title":"Universal directly observed therapy: a treatment strategy for tuberculosis.","volume":"18","author":"Weis","year":"1997","journal-title":"Clin. Chest Med."},{"key":"2026032708464964100_B5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/ajrccm.154.4.8887600","article-title":"Cost-effectiveness of directly observed versus self-adminstered therapy for tuberculosis.","volume":"154","author":"Moore","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708464964100_B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.112.1.63","article-title":"A cost-effectiveness analysis of directly observed therapy versus self-administered therapy for treatment of tuberculosis.","volume":"112","author":"Burman","year":"1997","journal-title":"Chest"},{"key":"2026032708464964100_B7"},{"key":"2026032708464964100_B8"},{"key":"2026032708464964100_B9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2105\/AJPH.88.7.1052","article-title":"Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?","volume":"88","author":"Bayer","year":"1998","journal-title":"Am. J. Public Health"},{"key":"2026032708464964100_B10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0272-5231(05)70366-X","article-title":"Supervised therapy in San Francisco.","volume":"18","author":"Schecter","year":"1997","journal-title":"Clin. Chest Med."},{"key":"2026032708464964100_B11"},{"key":"2026032708464964100_B12","first-page":"361","article-title":"Epidemiologic notes and reports: expanded tuberculosis surveillance and tuberculosis morbidity\u2014United States, 1993.","volume":"43","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2026032708464964100_B13"},{"key":"2026032708464964100_B14"},{"key":"2026032708464964100_B15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1164\/ajrccm.149.5.8173779","article-title":"Treatment of tuberculosis and tuberculous infection in adults and children.","volume":"149","author":"American Thoracic Society","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708464964100_B16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.96.4.815","article-title":"The tuberculosis clinic.","volume":"96","author":"Werhane","year":"1989","journal-title":"Chest"},{"key":"2026032708464964100_B17"},{"key":"2026032708464964100_B18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2105\/AJPH.86.8_Pt_1.1146","article-title":"Directly observed therapy for tuberculosis: the Harlem Hospital experience.","volume":"86","author":"El-Sadr","year":"1993","journal-title":"Am. J. Public Health"},{"key":"2026032708464964100_B19","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1164\/ajrccm.151.5.7735604","article-title":"Comprehensive tuberculosis control for patients at high-risk for noncompliance.","volume":"151","author":"Schluger","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708464964100_B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-5231(05)70363-4","article-title":"Directly observed therapy in New York City: history, implementation, results, and challenges.","volume":"18","author":"Fujiwara","year":"1997","journal-title":"Clin. Chest Med."},{"key":"2026032708464964100_B21"},{"key":"2026032708464964100_B22"},{"key":"2026032708464964100_B23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0140-6736(98)04022-7","article-title":"Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.","volume":"352","author":"Zwarenstein","year":"1998","journal-title":"Lancet"},{"key":"2026032708464964100_B24"},{"key":"2026032708464964100_B25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archinte.1995.00430150057006","article-title":"Health care expenditures for tuberculosis in the United States.","volume":"155","author":"Brown","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"2026032708464964100_B26"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/2\/582\/67427888\/ajrccm_160_2_582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/2\/582\/67427888\/ajrccm_160_2_582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:47:40Z","timestamp":1774615660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/160\/2\/582\/8529421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8,1]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1999,8,1]]},"published-print":{"date-parts":[[1999,8,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.160.2.9901049","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,8]]},"published":{"date-parts":[[1999,8,1]]}}}